Role of cyclophilin D in the resistance of brain mitochondria to the permeability transition

Abstract The mitochondrial permeability transition (MPT) is involved in both necrosis and apoptosis. Cyclophilin D (CypD) is an important component of the MPT. Brain mitochondria are more resistant to the MPT when compared to heart or liver mitochondria. We found that this increased resistance corre...

Full description

Saved in:
Bibliographic Details
Published inNeurobiology of aging Vol. 28; no. 10; pp. 1532 - 1542
Main Authors Eliseev, Roman A, Filippov, Gleb, Velos, Janice, VanWinkle, Beth, Goldman, Aaron, Rosier, Randy N, Gunter, Thomas E
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.10.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract The mitochondrial permeability transition (MPT) is involved in both necrosis and apoptosis. Cyclophilin D (CypD) is an important component of the MPT. Brain mitochondria are more resistant to the MPT when compared to heart or liver mitochondria. We found that this increased resistance correlates with low expression of CypD in brain when compared to heart or liver. In newborn rats, sensitivity of brain mitochondria to the MPT and CypD expression are significantly higher than in mature animals. In an in vitro model of neuronal development, mitochondria in differentiated neuronal-like cells exert a higher calcium threshold toward MPT induction and express significantly less CypD when compared to undifferentiated precursor cells. Gain and loss of function experiments confirm the role of CypD in sensitivity to the MPT. Together our data indicate that the increased calcium threshold of brain mitochondria to the MPT correlates with low expression of CypD in brain; and that neuronal cells lose CypD during differentiation and become less sensitive to the MPT induction. This may be a protection mechanism that raises the threshold of brain tissue against injuries.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0197-4580
1558-1497
DOI:10.1016/j.neurobiolaging.2006.06.022